Logo image of CS.PA

AXA SA (CS.PA) Stock Fundamental Analysis

EPA:CS - Euronext Paris - Matif - FR0000120628 - Common Stock - Currency: EUR

37.06  +0.69 (+1.9%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CS. CS was compared to 32 industry peers in the Insurance industry. Both the profitability and the financial health of CS get a neutral evaluation. Nothing too spectacular is happening here. CS is not valued too expensively and it also shows a decent growth rate. CS also has an excellent dividend rating. These ratings would make CS suitable for dividend investing!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CS was profitable.
In the past year CS had a positive cash flow from operations.
CS had positive earnings in each of the past 5 years.
In the past 5 years CS always reported a positive cash flow from operatings.
CS.PA Yearly Net Income VS EBIT VS OCF VS FCFCS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B 20B

1.2 Ratios

CS has a Return On Assets (1.12%) which is comparable to the rest of the industry.
CS's Return On Equity of 15.16% is in line compared to the rest of the industry. CS outperforms 60.00% of its industry peers.
CS has a Return On Invested Capital of 1.32%. This is comparable to the rest of the industry: CS outperforms 56.67% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CS is in line with the industry average of 2.08%.
The last Return On Invested Capital (1.32%) for CS is above the 3 year average (1.23%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.12%
ROE 15.16%
ROIC 1.32%
ROA(3y)1.01%
ROA(5y)0.77%
ROE(3y)12.73%
ROE(5y)9.51%
ROIC(3y)1.23%
ROIC(5y)1.01%
CS.PA Yearly ROA, ROE, ROICCS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10

1.3 Margins

With a Profit Margin value of 8.20%, CS is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
CS's Profit Margin has improved in the last couple of years.
With a Operating Margin value of 11.69%, CS perfoms like the industry average, outperforming 56.67% of the companies in the same industry.
In the last couple of years the Operating Margin of CS has grown nicely.
Industry RankSector Rank
OM 11.69%
PM (TTM) 8.2%
GM N/A
OM growth 3Y23.76%
OM growth 5Y4.76%
PM growth 3Y46.22%
PM growth 5Y36.38%
GM growth 3YN/A
GM growth 5YN/A
CS.PA Yearly Profit, Operating, Gross MarginsCS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2 4 6 8 10

5

2. Health

2.1 Basic Checks

CS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, CS has less shares outstanding
CS has less shares outstanding than it did 5 years ago.
The debt/assets ratio for CS has remained at the same level compared to a year ago.
CS.PA Yearly Shares OutstandingCS.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B
CS.PA Yearly Total Debt VS Total AssetsCS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200B 400B 600B 800B

2.2 Solvency

CS has an Altman-Z score of 0.34. This is a bad value and indicates that CS is not financially healthy and even has some risk of bankruptcy.
CS's Altman-Z score of 0.34 is amongst the best of the industry. CS outperforms 93.33% of its industry peers.
The Debt to FCF ratio of CS is 3.32, which is a good value as it means it would take CS, 3.32 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.32, CS is in line with its industry, outperforming 53.33% of the companies in the same industry.
CS has a Debt/Equity ratio of 0.57. This is a neutral value indicating CS is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.57, CS perfoms like the industry average, outperforming 56.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 3.32
Altman-Z 0.34
ROIC/WACC0.13
WACC10.16%
CS.PA Yearly LT Debt VS Equity VS FCFCS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 20B 40B 60B

2.3 Liquidity

A Current Ratio of 1.00 indicates that CS should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.00, CS is doing good in the industry, outperforming 80.00% of the companies in the same industry.
CS has a Quick Ratio of 1.00. This is a normal value and indicates that CS is financially healthy and should not expect problems in meeting its short term obligations.
CS's Quick ratio of 1.00 is fine compared to the rest of the industry. CS outperforms 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 1
CS.PA Yearly Current Assets VS Current LiabilitesCS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B

4

3. Growth

3.1 Past

CS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.49%, which is quite good.
CS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 32.03% yearly.
Looking at the last year, CS shows a very negative growth in Revenue. The Revenue has decreased by -11.35% in the last year.
The Revenue has been decreasing by -4.60% on average over the past years.
EPS 1Y (TTM)17.49%
EPS 3Y35.79%
EPS 5Y32.03%
EPS Q2Q%4.47%
Revenue 1Y (TTM)-11.35%
Revenue growth 3Y-9.14%
Revenue growth 5Y-4.6%
Sales Q2Q%-21.85%

3.2 Future

The Earnings Per Share is expected to grow by 5.80% on average over the next years.
The Revenue is expected to grow by 5.65% on average over the next years.
EPS Next Y6.81%
EPS Next 2Y8.71%
EPS Next 3Y7.94%
EPS Next 5Y5.8%
Revenue Next Year-13.58%
Revenue Next 2Y-4.81%
Revenue Next 3Y-3.63%
Revenue Next 5Y5.65%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CS.PA Yearly Revenue VS EstimatesCS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20B 40B 60B 80B 100B
CS.PA Yearly EPS VS EstimatesCS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 11.47, which indicates a very decent valuation of CS.
CS's Price/Earnings is on the same level as the industry average.
CS is valuated cheaply when we compare the Price/Earnings ratio to 28.47, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 9.23, the valuation of CS can be described as reasonable.
CS's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 92.74, CS is valued rather cheaply.
Industry RankSector Rank
PE 11.47
Fwd PE 9.23
CS.PA Price Earnings VS Forward Price EarningsCS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as CS.
Industry RankSector Rank
P/FCF 10.15
EV/EBITDA N/A
CS.PA Per share dataCS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

CS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.68
PEG (5Y)0.36
EPS Next 2Y8.71%
EPS Next 3Y7.94%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.40%, CS is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.01, CS pays a bit more dividend than its industry peers.
CS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.28.
Industry RankSector Rank
Dividend Yield 5.4%

5.2 History

The dividend of CS has a limited annual growth rate of 4.19%.
Dividend Growth(5Y)4.19%
Div Incr Years3
Div Non Decr Years3
CS.PA Yearly Dividends per shareCS.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 0.5 1 1.5 2 2.5

5.3 Sustainability

CS pays out 62.10% of its income as dividend. This is not a sustainable payout ratio.
The dividend of CS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP62.1%
EPS Next 2Y8.71%
EPS Next 3Y7.94%
CS.PA Yearly Income VS Free CF VS DividendCS.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B 20B
CS.PA Dividend Payout.CS.PA Dividend Payout, showing the Payout Ratio.CS.PA Dividend Payout.PayoutRetained Earnings

AXA SA

EPA:CS (2/4/2025, 7:00:00 PM)

37.06

+0.69 (+1.9%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)08-01 2024-08-01/amc
Earnings (Next)02-27 2025-02-27/amc
Inst Owners41.04%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap82.06B
Analysts80.71
Price Target40.45 (9.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.4%
Yearly Dividend1.76
Dividend Growth(5Y)4.19%
DP62.1%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.15%
PT rev (3m)2.14%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.22%
EPS NY rev (3m)-1.22%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-4.43%
Revenue NY rev (3m)-4.43%
Valuation
Industry RankSector Rank
PE 11.47
Fwd PE 9.23
P/S 0.94
P/FCF 10.15
P/OCF 9.59
P/B 1.73
P/tB 3.35
EV/EBITDA N/A
EPS(TTM)3.23
EY8.72%
EPS(NY)4.02
Fwd EY10.83%
FCF(TTM)3.65
FCFY9.85%
OCF(TTM)3.87
OCFY10.43%
SpS39.51
BVpS21.38
TBVpS11.07
PEG (NY)1.68
PEG (5Y)0.36
Profitability
Industry RankSector Rank
ROA 1.12%
ROE 15.16%
ROCE 1.63%
ROIC 1.32%
ROICexc 1.37%
ROICexgc 1.79%
OM 11.69%
PM (TTM) 8.2%
GM N/A
FCFM 9.24%
ROA(3y)1.01%
ROA(5y)0.77%
ROE(3y)12.73%
ROE(5y)9.51%
ROIC(3y)1.23%
ROIC(5y)1.01%
ROICexc(3y)1.28%
ROICexc(5y)1.05%
ROICexgc(3y)1.64%
ROICexgc(5y)1.33%
ROCE(3y)1.52%
ROCE(5y)1.25%
ROICexcg growth 3Y24.63%
ROICexcg growth 5Y6.98%
ROICexc growth 3Y21.16%
ROICexc growth 5Y7.2%
OM growth 3Y23.76%
OM growth 5Y4.76%
PM growth 3Y46.22%
PM growth 5Y36.38%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 3.32
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.55%
Interest Coverage 1.51
Cash Conversion N/A
Profit Quality 112.61%
Current Ratio 1
Quick Ratio 1
Altman-Z 0.34
F-Score7
WACC10.16%
ROIC/WACC0.13
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.37%
Cap/Sales(5y)0.36%
Profit Quality(3y)112.32%
Profit Quality(5y)257.76%
High Growth Momentum
Growth
EPS 1Y (TTM)17.49%
EPS 3Y35.79%
EPS 5Y32.03%
EPS Q2Q%4.47%
EPS Next Y6.81%
EPS Next 2Y8.71%
EPS Next 3Y7.94%
EPS Next 5Y5.8%
Revenue 1Y (TTM)-11.35%
Revenue growth 3Y-9.14%
Revenue growth 5Y-4.6%
Sales Q2Q%-21.85%
Revenue Next Year-13.58%
Revenue Next 2Y-4.81%
Revenue Next 3Y-3.63%
Revenue Next 5Y5.65%
EBIT growth 1Y4.29%
EBIT growth 3Y12.44%
EBIT growth 5Y-0.05%
EBIT Next Year26.06%
EBIT Next 3Y9.55%
EBIT Next 5YN/A
FCF growth 1Y9.42%
FCF growth 3Y-33.47%
FCF growth 5Y-1.8%
OCF growth 1Y11.23%
OCF growth 3Y-32.45%
OCF growth 5Y-1.79%